Emergen Research Logo

Surge in research activities on preclinical research, antibody therapies, and advanced drug discoveries are key factors driving antibody-drug conjugates market

VANCOUVER, BC, CANADA, June 20, 2023/EINPresswire.com/ -- The global Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research.

Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.

A new class of biopharmaceuticals known as antibody-drug conjugates (ADCs) has evolved that combines the cytotoxicity of small molecule medications with the specificity of monoclonal antibodies (mAbs). This ground-breaking method has paved the path for extremely tailored medicines in oncology and other fields. The quest for personalised medicine and the need for more potent treatment options for complex diseases have caused the market for ADCs to experience impressive expansion in recent years.

A monoclonal antibody, a cytotoxic payload, and a linker that joins the three make up the essence of an ADC. Accurate targeting is made possible by the monoclonal antibody's preferential binding to particular antigens expressed on the surface of cancer cells. Localised cell death results from the release of the cytotoxic payload once the ADC has been bound and internalised. By reducing the off-target toxicities linked to conventional chemotherapy, this focused method increases therapeutic efficacy while reducing side effects.

Download Sample Copy of Antibody-Drug Conjugates Report@ https://www.emergenresearch.com/request-sample/754

Moreover, the study provides Porter’s five forces model, along with portfolio and financial analysis and business overview of services and products. The report outlines market segmentation and growth analysis of the top 10 market players that are currently active in the Antibody-Drug Conjugates industry. The report also contains information and statistics, tables and figures that are used in strategic planning for the company's success.

Key Players Mentioned in the Antibody-Drug Conjugates Market Research Report:

Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Some Key Highlights from the Report

In July 2021, ProfoundBio announced completion of USD 55 million Series A funding on advance novel antibody-drug conjugate portfolio. The financing is being led by Lilly Asia Venture and co-led by LYFE Capital, with participation from Oriza and Sequoia Capital China. ProfoundBio will use the funds to accelerate development of ADCs and IO therapeutics.

Non-cleavable linkage segment accounted for larger revenue share in 2020 owing to greater advantages over cleavable linkers due to increased plasma stability. These linkers can potentially offer a greater therapeutic window due to the fact that the payload derivative from non-cleavable ADCs can kill target cells. It also provides great tolerability and stability.

Lung cancer is among the leading causes of deaths in both men and women globally. Despite development in treatments, patients with cancer continue to suffer with limited treatment options. ADC has emerged as a significant therapy for lung cancer as it has tumor specificity and powerful tumor-killing effect.

Access complete report@ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market

Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018–2028)

Cleavable Linker

Non-Cleavable Linker

Application Outlook (Revenue, USD Billion; 2018–2028)

Blood Cancer

Leukemia

Lymphoma

Brain Tumor

Ovarian Cancer

Breast Cancer

Lung Cancer

Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals

Research Institute

Clinics

Inquiry for customization or any other related questions at@  https://www.emergenresearch.com/request-for-customization/754

You need to discover how this will impact the Antibody-Drug Conjugates market today, and over the next 10 years:

• Our 250-page report provides 194 tables and 189 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – Now.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you Today how the Antibody-Drug Conjugates market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Buy a Antibody-Drug Conjugates market report here@ https://www.emergenresearch.com/select-license/754

Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.

Look Over transcripts provided by Emergen Research 

Microarray Market

https://www.emergenresearch.com/industry-report/microarray-market

GPS Tracking Device Market

https://www.emergenresearch.com/industry-report/gps-tracking-device-market 

Smart and Solar Flower Market

https://www.emergenresearch.com/industry-report/smart-and-solar-flower-market

Emergency Lighting Market

https://www.emergenresearch.com/industry-report/emergency-lighting-market

Shared Satellite Services Market

https://www.emergenresearch.com/industry-report/shared-satellite-services-market

Photovoltaic Market

https://www.emergenresearch.com/industry-report/photovoltaic-market

White Spirit Market

https://www.emergenresearch.com/industry-report/white-spirit-market

Sports Nutrition Market

https://www.emergenresearch.com/industry-report/sports-nutrition-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.